Patent · US Expired

Antithrombotic quinoxazolines

US6200976A · kind A · utility

6Cited by

0References

11Claims

0Family size

Assignee

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

Uwe Ries · Biberach an der Riß, DE
Norbert Hauel · Schemmerhofen, DE
Henning Priepke · Warthausen, DE
Herbert Nar · Ochsenhausen, DE
Jean-Marie Stassen · Bad Buchau, DE
Wolfgang Wienen · Äpfingen, DE

Key dates

Filing date	Mar 29, 1999
Grant date	Mar 13, 2001
Priority date	—
Expiry date	Mar 29, 2019

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Quinoxazolines having antithrombotic activity. Exemplary of those disclosed are: PA1 4-{[6-(N-carboxymethyl-quinolin-8-yl-sulphonylamino)-1-methyl-2-oxo-1,2-dih ydroquinoxalin-3-yl]-methyl}-benzamidine, PA1 4-{[6-(1-(N-cyclopentyl-carboxymethylcarbonylamino)-cyclo-propyl)-1-methyl- 2-oxo-1,2-dihydroquinoxalin-3-yl]-methyl}-benzamidine, and PA1 4-{[7-(N-carboxymethylaminocarbonyl-ethylamino)-4-methyl-quinolin-2-yl]-oxo }-benzamidine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.